Pinsent Masons advises on Epwin and Latium Merger

02 Feb 2012 | 10:58 am |

International law firm Pinsent Masons has advised Epwin (Holdings) Limited on its merger with Latium Group. The merger forms a new UK building products group with a turnover in excess of £275m.

Epwin is a leading building products provider in the UK with key brands in window material supply. The Epwin Group was founded in 1976 and has over 2,500 employees.

Jim Rawson, Founder and Chairman of Epwin, commented: "This is a major opportunity for the UK building products industry. In bringing together many of its leading businesses, in a British run, British owned group, we have the resource to invest in individual brands, product innovation and service, grow our business and most importantly, support our customers across sectors in doing the same."

 The Pinsent Masons team advising on the deal was led by Corporate Partner Paul Harkin and Senior Associate Zanna Patchett, assisted by Rhian Critchell and Christian Mulvihill. The banking team was led by Banking Senior Associate Esther Parkes and Associate Pippa Whitmore.

Commenting on the deal, Paul Harkin said: "We are delighted to have advised on the merger and wish the Group every success."

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

Pinsent Masons advises ALK Capital on its acquisition of Burnley FC

Multinational law firm Pinsent Masons has advised ALK Capital on the acquisition of Burnley Football Club.

Pinsent Masons advises Unbound on financing in fitness start-up VAHA

Pinsent Masons has advised Unbound on its investment in etone Motion Analysis GmbH (VAHA), a manufacturer of smart digital mirrors.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts